Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.Title250. Improvements in quality of life in behçet's syndrome patients treated with apremilast: a phase 3 randomized, double-blind, placebo-controlled study.AuthorsHatemi, Gülen; Mahr, Alfred; Takeno, Mitsuhiro; Kim, Doyoung; Melikoglu, Melike; Cheng, Sue; McCue, Shannon; Paris, Maria; Chen, Mindy; Yazici, YusufSubjectsPENNSYLVANIA; BEHCET'S disease; CONFERENCES &; conventions; HEALTH outcome assessment; QUALITY of life; THALIDOMIDE; RANDOMIZED controlled trialsPublicationRheumatology, 2019, Vol 58, pN.PAGISSN1462-0324Publication typeAbstractDOI10.1093/rheumatology/kez062.024